ABSTRACT Purpose: This systematic review aimed to assess the available literature for regenerative treatment of peri-implantitis using bone graft substitutes and membranes. Methods: A search in electronic databases was conducted to assess all types of clinical studies treating bone defects derived from peri-implantitis using guided bone regeneration (GBR) techniques. Results: During the first screening, 399 titles were identified. Finally, 17 articles reporting on 173 implants were included. The articles mainly focused on radiographic bone fill of the defect. Qualitative measures of "bone fill" were reported: 10.4% of the implants showed complete "bone fill," whereas 85.5% revealed incomplete defect closure. No bone fill was shown in 4.0%. Little information (in 53.2%) was provided regarding the probing depth before or after treatment. Data concerning the inflammatory status of soft tissues were also scarce and only reported in three studies. A large heterogeneity concerning disinfection protocols and regenerative materials used was found. The high percentage of low-quality studies rendered a meta-analysis impossible. Conclusion: Complete fill of the bony defect using GBR seems not to be a predictable outcome. The mucosal health status is left unconsidered in most studies. Well-controlled trials are needed to determine predictable treatment protocols for the successful regenerative treatment of peri-implantitis using GBR technique.
Introduction
During the last decades, the use of dental implants has become a routine procedure in dentistry to replace one or more missing teeth. Using implant survival as the indicator of successfull clinical outcome, a majority of clinical studies have shown very positive results for dental implants. 1 However, limited focus has been put on peri-implant mucosal health thus far. Recent studies reported a rate of 8.6% -9.7% of chronic inflammation of soft and hard tissues neighbouring implants after five years. 2, 3 Lately, a comprehensive investigation concluded, that the periimplant inflammation is a common clinical finding about ten years after implantation. 4 The pathologic conditions termed mucositis and "peri-implantitis" are considered the major complication in dental implantology. 3 Clinical manifestations like gingival bleeding, swelling and at a later state, bone loss highly resemble periodontal inflammation. Plenty of research has been conducted, proving that both diseases have a bacterial etiology with a similar spectrum of pathogens. [5] [6] [7] In analogy to periodontitis and gingivitis, peri-implantitis can be distinguished from mucositis by the clinical finding of attachment loss to supporting tissues, i.e. to the supporting bone. Thus, increased peri-implant probing depth and radiographic bone loss around the implant's neck are considered the most reliable parameters proving peri-implantitis. 8, 9 Additionally, bleeding on periodontal probing (BOP), though an indicator for mucositis and not peri-implantitis, is a relevant parameter for the risk assessment of peri-implantitis. 10 A broad variety of different treatment modalities have been proposed for the treatment of periimplantitis and there is still a lack of evidence concerning their indication and outcome. 11 At the turn of the millenium a systematic treatment scheme called "Cumulative Interceptive Supportive
Therapy" (CIST) 9 was formulated. Based on clinical and radiographical findings, a peri-implant lesion was categorized into a maintenance classification system, which consistently lead to a specific treatment recommendation. In the CIST-protocol, regenerative surgery using Guided
Tissue Regeneration (GTR) techniques is recommended to fill bony defects caused by periimplantitis. Due to the fact that in peri-implantitis treatment regeneration is limited to bony tissue the term "Guided Bone Regeneration" (GBR) has obtained acceptance in the literature. 12 There have numerous case reports, case series and clinical trials been published reporting on GBR-techniques in peri-implantitis treatment, in which a combination of both membranes and bone graft substitutes was used. However, there is limited evidence on success and reliability of that treatment protocol. The aim of the present review was to systematically evaluate the outcome of GBR using a bone graft substitute in combination with a membrane to treat bone defects derived from peri-implantitis on the basis of the parameters peri-implant probing depth (PPD), bleeding-on-probing (BOP) and marginal bone loss (BL).
Material and methods

Search method
Using 
Screening and Selection
In a first step, titles and abstracts of the electronic search were independently screened by two reviewers (PS, PRS) and assessed for possible inclusion in the review.
-RCT studies comparing interventions using membrane and bone graft substitutes to control groups treated without GBR techniques.
Non-randomized clinical trials and case reports and series.
Only cases treating bone defects derived from marginal peri-implantitis were considered. Studies dealing with peri-apical peri-implantitis were not included due to its different etiology and therapeutic approaches.
With respect to a valid comparability of the treatment modalities, only publications reporting on a treatment protocol including application of both membrane (resorbable and non resorbable) and bone substitutes were included.
In a second step, the full texts of all possibly relevant studies, including manually retrieved articles, were then evaluated separately and independently by the same reviewers. Disagreement between the reviewers was resolved by discussion.
From the included articles the data for the assessment parameters probing depth around implants (PPD), bleeding-on-probing (BOP) and bone level (BL) were extracted if given. The difference of these values before and after treatment and their weighted means were calculated if possible.
For publications providing only means and standard deviations for a collective of peri-implantitis cases, differences of the means were calculated. In some cases, more detailed data from the authors of the more comprehensive studies was requested.
Results
Initially 399 titles and abstracts from the electronic search were screened and assessed for possible inclusion in the review. Out of these, titles that obviously did not meet the inclusion criteria were excluded in a first step and 62 studies remained for further analysis. Four additional articles were included by manual search and two by the "related links function". These 68 studies were then separately and independently evaluated by the reviewers. In this step, a further 51 articles were excluded. The main reasons for exclusion were: animal studies (12) 13-24 , review
articles ( Disagreement between the reviewers in 4.4 % of the cases was consequently resolved by discussion.
From finally remaining 17 original articles, including 173 treated implant cases, the data for the assessment parameters bleeding-on-probing (BOP), periodontal probing depth (PPD) and bone level (BL) was extracted if given.
Description of the studies
No RCT studies comparing peri-implantitis treatment by using membrane and bone graft substitutes to a non-GBR treatment were found. 
Bleeding on Probing
Of the 17 included articles five studies reported on pre-treatment BOP values, but only three of these also reported on post-treatment data. It has to be noted, that most study designs included an immediate conservative treatment like rinsing of the peri-implant pockets prior to surgical treatment, so BOP values at baseline might differ from those immediately before intervention.
Two studies suggested absence of BOP after intervention when "healthy and firm mucosa" was found 70,71 (figure 2). A weighted mean value of bone win of 2.1 mm was calculated after GBR treatment (table 2) .
Bone fill
The residual mean bone defect depth at the time of reevaluation was 2.6 mm.
Twelve studies reported qualitative or semi-quantitative informations like "partial" or not further specified "bone fill" without providing any quantitative data (table 4, figure 3 ).
Discussion
This review aimed to assess the outcome of peri-implantitis treatment using membranes and bone graft substitutes. Unfortunately, there were no RCT studies comparing the results of periimplantitis treatment with GBR-techniques using both membrane and bone graft substitute, to an adequate control group, i.e. scaling or non-regenerative surgery. Consequently, studies of a lower level of evidence, like case presentations and proportions of patient cohorts from RCT studies with a different aim, were included in order to benefit from the available data in literature and to investigate possible differences the quality of data presentation. The risk of including confounding factors was estimated low as with GBR techniques the plausibility of interventionoutcome affinity is high. Therefore, it was decided to enclose these non-controlled studies in the analysis.
Furthermore, there was a lack of studies with numerous implants: The majority of the studies presented data of single cases or small case series. Only six studies included more than 7
implants. These studies assessed clinical parameters like BOP and PPD more often. However, incomplete data presentation in these studies hampered comparability and rendered a metaanalysis impossible.
This study focussed on GBR techniques using both, bone graft substitute and membrane: this treatment modality represents the major part of published GBR cases. Hence, studies using solely one of both materials, were excluded in order not to further jeopardize the validity of comparison.
There are a multitude of different implant systems with varying fixture design and different surfaces combined with a diversity of bone graft substitutes and barrier membranes. Therefore, comparison among the different peri-implant surgery cases is also problematic.
Observation periods in the included studies ranged from five months to three years, and reexamination intervals varied greatly. Thus, a comparison after the same period for all studies was impossible. Moreover, short observation times strongly limit the clinical relevance of the treatment outcome. Long-term follow-up examinations are required for a more valid assessment.
Not surprisingly, all studies investigated radiographic bone morphology. However, less attention was paid to crucial clinical parameters like BOP and PPD. These parameters were rarely reported. This conflicts with the recommendations of the American Academy of Periodontology and the European Workshop on Periodontology which explicitly call for the data collection of BOP and PPD in the examination of peri-implantitis cases. 76, 77 This finding indicates a shortcoming in soft tissue evaluation and is in accordance with a lately published review on periimplantitis therapy. 78 Still, the etiology of marginal bone defects around implants is a topic of debate: Reasons for marginal peri-implant bone loss like adverse occlusal loading effects from hyper-contacts 79, 80 unfavourable healing 81 and the effect of position and adaption of the microgap 82 are common topics of the discussion about peri-implant bone loss. However, studies in periodontology prove a pivotal role of the soft tissues in the inflammation process.
The authors concluded a mean probing depth reduction of 3.29 mm and a residual probing depth of 3.23 mm. It is thereby estimated that a peri-implant probe penetrates approximately 3 mm in a healthy situation 83, 84 and according to the CIST protocol no further invasive intervention is indicated. Therefore, these results seem to suggest peri-implant health. However, it must be considered that the calculated PPD mean value was derived from a broad range of PPD values varying from study to study and even from case to case.
There is clear evidence that peri-implantitis processes start as a peri-mucosal inflammation from the most external contact of implant and tissues, i.e. from the mucosal seal around the implant neck. 7, 29, 85 Analog to the transition from gingivitis to periodontitis the drawdown of attachment level is the crucial symptom to distinguish peri-mucositis from peri-implantitis. As early as in the 1980s, it was shown that the PPD differs from the histological pocket depth in periodontal sites. 86 In inflamed periodontal situations probes tend to penetrate deeper into the tissues because of the decreased tenseness of the soft tissues. The same effect, though more pronounced, has been shown for peri-implant situations. 87, 88 This finding underlines that PPD assessment is an even more sensitive instrument for the detection of attachment loss in potentially inflamed situations. The inaccuracies of deeper probe penetration should not restrain practitioners from using this diagnostic tool: as inflammation fades in the course of treatment the difference between clinical and histological pocket depth will decrease and in the same way the accuracy of the parameter PPD will increase. Contrary to sporadically expressed assumptions, there is no evidence that careful peri-implant probing could damage the implant surface or create persistant injury to the tissues. 9, 89 Noteworthy, only three of 17 studies reported on BOP measurements. With regard to BOP assessment it has been shown in periodontal sites that absence of bleeding after probing is a reliable predictor for periodontal stability. [89] [90] [91] Consequently, BOP assessment is most reasonable for both peri-implantitis screening and evaluation of a peri-implantitis treatment.
With regard to bone fill most of the studies provided only qualitative or semi-quantitative data for the amount of fill of the intrabony defect. For better comparability improved parameters for the defect size characterization would be helpful. For this purpose, reliable and quick methods have been published. 92, 93 In this review, 10.4% of the included implant collective showed a complete and 85.5% at least a partial defect fill. This amounts to 96% of all analyzed cases where a bonefill of whatsoever extent was achieved by GBR technique. In this respect, GBR treatment can be assumed to lead to rather safe success. The interpolated 2.6 mm of residual bone defect after surgery should be interpreted with caution: both the reference level, i.e. implant benchmarks or neighbouring bone level, and the calculation might lead to inadequate conclusions. Anyhow, it should be kept in mind that there is no evidence for the need of either complete or incomplete defect fill.
The assessment of the crestal bone level on conventional radiographs has been proven to be a highly specific testing method. 94 Thus, an initial peri-implant defect is not easily detected on the radiograph: Studies show that on conventional radiographs the sensitivity for identification of smaller defects, as expected for the onset peri-implant defect, is low. 94, 95 Considerable improvements with CT and DVT technique have recently been reported. 96 Of course, the radiographs provide no information about the nature of bone and interface. It is indeterminable in an augmented site with an apparently dense bone formation at the implant's neck, whether osseointegration on a histological level has actually occured. 94 Putting the main focus on radiographic bone fill relies on a phenomenon of doubtful nature; there is still no evidence showing what kind of structure actually fills the bone defect. Furthermore, there is disagreement in research about the amount of remaining bone substitute and regenerated genuine bone, which can be expected depending on resorption time of the various bone graft materials. show a high stability in volume, but remain nearly or completely unresorbed even several years after surgery. 100 In clinical practice, this implies that visual bone fill on the x-ray per se is not sufficient to claim a successful biological outcome after peri-implantitis treatment, 101 especially in the long-term.
Conclusion
Complete fill of bony defects caused by peri-implantitis using a GBR-protocol with membrane and bone graft substitutes does not seem to be a predictable outcome, although a partial defect fill can be expected.
Published peri-implantitis literature lacks comprehensive studies with high number of cases that would enable a sound statistical analysis. The mucosal health status as a reliable indicator for peri-implant inflammation, reflected by the parameters BOP and PPD, is not reported in the majority of the studies.
RCT studies comparing GBR treatment to non-invasive debridement in peri-implantitis cases are needed in order to provide evidence for an additional benefit of the use of bone graft substitutes and membranes. In these studies, assessment of quantitative values for bone loss, PPD and BOP would be desirable. 
